day 1 agenda

Tentative Program
Day -1: June (20, 2024)
Oral Presentations
Keynote Title: Targeted Nanotherapy using CRISPR/Cas9 for Genetically Knocking down Highly Specific Genes for Basal-like Breast Cancer
Dipanjan Pan, The Pennsylvania State University, USA
Keynote Title: Phytochemical screening and GC-MS chemical profiling of an innovative anti-cancer herbal formula (PHF6)
Mohammed Al-Zharani, Imam Mohammad Bin Saud Islamic University, Saudi Arabia
                       SPEAKER SLOT AVAILABLE
  Title: Benefits of adjuvant Pingxiao capsule in patients with early breast cancer: A single-center Retrospective cohort study
Xinyu Zheng,  First Hospital of China Medical University, United States
  Title: A study of human epidermal growth factor receptor 2 overexpression by immunohistochemistry in patients with gastric adenocarcinoma
Saad Alomar, College of Medicine - University of Basrah, Iraq
                       SPEAKER SLOT AVAILABLE
  Title: Reduction of Radiation Dose in Full-Field Digital Mammography (FFDM) With Massive-Training Artificial Neural Network
Kenji Suzuki, Tokyo Institute of Technology, Japan
  Title: Targeted demethylation of the CDO1 promoter based on CRISPR system inhibits the malignant potential of breast cancer cells
Qin Li, Sun Yat-sen Memorial Hospital, China
Lunch Break
Keynote Title: Targeting AKT2 in MDA-MB-231 Cells by Pyrazole Hybrids: Structural, Biological and Molecular Docking Studies
Anup N Kate, MES Abasaheb Garware College, India
Keynote                      SPEAKER SLOT AVAILABLE
  Title: The extended intercostal artery perforator flap: expanding the indication for autologous partial immediate breast reconstruction
Maged, Norfolk and Norwich university hospital, United Kingdom
  Title: Evaluation of Axilla With Sentinel Lymph Node Biopsy (Using Methylene- Blue) and Reverse Axillary Mapping (Using Fluorescein) to Validate Optimum and Safe Axillary Dissection in Breast Cancer       
Aswin Puthangot , Mother care hospital, Mannarkkad, kerala, India
                       SPEAKER SLOT AVAILABLE
  Title:  TBA
Katia Cortese, University of Genoa, Italy
  Title: Diagnostic Contrast-Enhanced Mammography Performed Immediately Prior to Same-Day Biopsy: An Analysis of Index Lesion Enhancement Compared to Histopathology and Follow-up in Patients With Suspicious Ultrasound Findings
Jessica Kuehn-Hajder, University of Minnesota, USA
  Title:  TBA
Aktas Safiye, Dokuz Eylul University, Turkey
Refreshment Break
  Title:  TBA
Amany Ghazy , Kafrelsheikh University, Egypt
  Title: Relationships Between Biological Heavy Metals and Breast Cancer
Xue Li, Shanghai Jiao Tong University, China
                       SPEAKER SLOT AVAILABLE
  Title: EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-Like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome
Annabi Borhane, Université du Québec à Montréal, Canada
Day-1 Concludes
Note: This is the tentative program only and the program will be updated by Feb
If any one interested to attend the conference or to book your speaker slot, please send an email to 

day 2 agenda

Day -2: June (21, 2024)
Oral Presentations
  Title: Increased YAP1 expression is significantly associated with breast cancer progression, metastasis and poor survival
Javeria Qadir, COMSATS University Islamabad, Canada
                       SPEAKER SLOT AVAILABLE
  Title: In-Vivo Gene Delivery into Mouse Mammary Epithelial Cells Through Mammary Intraductal Injection
Wen Bu, Baylor College of Medicine, USA
                       SPEAKER SLOT AVAILABLE
  Title: Artificial Intelligence for Breast Cancer mass segmentation in Dynamic Contrast Enhanced MRI and Discrimination of Infiltrative versus In Situ Carcinoma
Luana Conte, University of Salento, Italy
                       SPEAKER SLOT AVAILABLE
  Title: Anesthesia Considerations to Reduce Acute and Chronic Pain After Mastectomy Surgery for Breast Cancer
Berger Jack, University of Southern California, USA
                       SPEAKER SLOT AVAILABLE
Lunch Break
  Title: Discovery of a highly potent, orally bioavailable estrogen receptor full antagonist and degrader giredestrant (GDC-9545) for estrogen receptorpositive breast cancer
Jun Liang, Harvard University, USA
                       SPEAKER SLOT AVAILABLE
  Title: Efect of Delayed Oncoplastic Reduction Mammoplasty on Radiation Treatment Delay Following Breast Conserving Surgery for Breast Cancer
Hadzikadic-Gusic Lejla, Levine Cancer Institute LLC, USA
                       SPEAKER SLOT AVAILABLE
  Title: Disruption of the pentraxin 3 CD44 interaction as an efficient therapy for triple-negative breast cancers
Wang Ju Ming, National Cheng Kung University, Taiwan
                       SPEAKER SLOT AVAILABLE


  Title: Exploring Breast Cancer Systemic Drug Therapy Patterns in Real World Data
Julia ORourke, TriNetX, Cambridge, USA
  Title: Radiation Therapy in Patients with Germline Mutations a Review of the Current Evidence
Sabih Qurat Ul Ain, University of Pittsburgh Medical Center, USA
                       SPEAKER SLOT AVAILABLE
  Title: A Study on Clinico Pathological Profile of Breast Cancer Patients and Their Correlation With Uterine Fibroids Using Hormone Level and Receptor Status Assessment
Bharati Pandya, AIIMS Bhopal, India
  Title: NTF4 plays a dual role in breast cancer in mammary tumorigenesis and metastatic progression
Ran Sun, Chongqing Jiulongpo People's Hospital, China
                       SPEAKER SLOT AVAILABLE
Note: This is the tentative program only and the program will be updated by Feb
If any one interested to attend the conference or to book your speaker slot, please send an email to